Form 8-K - Current report:
SEC Accession No. 0001104659-24-106284
Filing Date
2024-10-04
Accepted
2024-10-04 16:30:13
Documents
16
Period of Report
2024-09-30
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2425569d1_8k.htm   iXBRL 8-K 28613
2 EXHIBIT 16.1 tm2425569d1_ex16-1.htm EX-16.1 3249
6 GRAPHIC tm2425569d1_img001.jpg GRAPHIC 9883
7 GRAPHIC tm2425569d1_img002.jpg GRAPHIC 3059
  Complete submission text file 0001104659-24-106284.txt   227157

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA snpx-20240930.xsd EX-101.SCH 3021
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE snpx-20240930_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snpx-20240930_pre.xml EX-101.PRE 22363
18 EXTRACTED XBRL INSTANCE DOCUMENT tm2425569d1_8k_htm.xml XML 3802
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 9732420005
Synaptogenix, Inc. (Filer) CIK: 0001571934 (see all company filings)

EIN.: 461585656 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40458 | Film No.: 241355251
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)